CR9597A - Formulaciones de estrogenos conjugados y bazedoxifeno - Google Patents

Formulaciones de estrogenos conjugados y bazedoxifeno

Info

Publication number
CR9597A
CR9597A CR9597A CR9597A CR9597A CR 9597 A CR9597 A CR 9597A CR 9597 A CR9597 A CR 9597A CR 9597 A CR9597 A CR 9597A CR 9597 A CR9597 A CR 9597A
Authority
CR
Costa Rica
Prior art keywords
strogens
bazedoxifen
conjugated
formulations
bazedoxifene
Prior art date
Application number
CR9597A
Other languages
English (en)
Inventor
Ramarao S Chatlapalli
Arwinder Nagl
Pelt Lawrence Van
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37401610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9597(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9597A publication Critical patent/CR9597A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

La presente invencion tiene relacion con formulaciones de dosificacion solidas conteniendo estrogenos conjugados y bazedoxifeno, o una sal de ellos. En algunas modalidades las composiciones incluyen un nucleo comprende estrogenos conjugados y a lo menos una cobertura que comprende bazedoxifeno o una sal de ellos.
CR9597A 2005-06-29 2007-12-17 Formulaciones de estrogenos conjugados y bazedoxifeno CR9597A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69488905P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
CR9597A true CR9597A (es) 2008-03-06

Family

ID=37401610

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9597A CR9597A (es) 2005-06-29 2007-12-17 Formulaciones de estrogenos conjugados y bazedoxifeno

Country Status (19)

Country Link
US (1) US20070003623A1 (es)
EP (1) EP1898888A2 (es)
JP (1) JP2008545012A (es)
KR (1) KR20080031037A (es)
CN (1) CN101252921A (es)
AR (1) AR054806A1 (es)
AU (1) AU2006263638A1 (es)
BR (1) BRPI0612586A2 (es)
CA (1) CA2613102A1 (es)
CR (1) CR9597A (es)
EC (1) ECSP078057A (es)
IL (1) IL188223A0 (es)
NI (1) NI200700331A (es)
NO (1) NO20080002L (es)
PA (1) PA8684501A1 (es)
PE (1) PE20070188A1 (es)
RU (1) RU2395286C2 (es)
TW (1) TW200738283A (es)
WO (1) WO2007002823A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1732528A1 (en) * 2004-04-08 2006-12-20 Wyeth Bazedoxifene acetate solid dispersion formulations
JP2010511062A (ja) * 2006-11-29 2010-04-08 ワイス エルエルシー エストロゲン／ｓｅｒｍおよびエストロゲン／プロゲスチン二層錠剤
RU2009125413A (ru) * 2007-01-12 2011-02-20 Вайет (Us) Композиции таблетка-в-таблетке
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
ES2436841T3 (es) 2009-10-27 2014-01-07 Wyeth Llc Formulaciones de bazedoxifeno con antioxidantes
NZ602955A (en) * 2010-04-20 2015-02-27 Cipla Ltd Pharmaceutical composition comprising efavirenz
US8615061B2 (en) * 2010-07-29 2013-12-24 Entropic Communications, Inc. Method and apparatus for cross polarization and cross satellite interference cancellation
BR112013029199B1 (pt) * 2011-05-13 2022-02-08 Eb Ip Hybritabs B.V. Dispositivo de distribuição de dois fármacos
CN104013630B (zh) * 2014-05-23 2018-08-21 合肥九研医药科技开发有限公司 一种复方醋酸巴多昔芬雌激素组合物
KR102662025B1 (ko) 2015-06-18 2024-05-02 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018182205A1 (ko) * 2017-03-30 2018-10-04 한미약품 주식회사 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AU5957500A (en) * 1999-07-06 2001-01-22 Endorecherche Inc. Methods of treating and/or suppressing weight gain
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
BR0311774A (pt) * 2002-06-13 2007-05-08 Wyeth Corp regimes de tratamento com bazedoxifeno
TW200536845A (en) * 2004-04-07 2005-11-16 Wyeth Corp Crystalline polymorph of bazedoxifene acetate
JP2007532560A (ja) * 2004-04-07 2007-11-15 ワイス バゼドキシフェンアセテートの結晶多形
US7504394B2 (en) * 2004-04-08 2009-03-17 Wyeth Bazedoxifene ascorbate
EP1732528A1 (en) * 2004-04-08 2006-12-20 Wyeth Bazedoxifene acetate solid dispersion formulations

Also Published As

Publication number Publication date
JP2008545012A (ja) 2008-12-11
TW200738283A (en) 2007-10-16
NI200700331A (es) 2009-02-16
WO2007002823A2 (en) 2007-01-04
AR054806A1 (es) 2007-07-18
PE20070188A1 (es) 2007-03-16
IL188223A0 (en) 2008-03-20
BRPI0612586A2 (pt) 2010-11-23
NO20080002L (no) 2008-03-12
RU2395286C2 (ru) 2010-07-27
US20070003623A1 (en) 2007-01-04
PA8684501A1 (es) 2007-01-17
KR20080031037A (ko) 2008-04-07
WO2007002823A3 (en) 2007-08-09
ECSP078057A (es) 2008-01-23
AU2006263638A1 (en) 2007-01-04
RU2007148071A (ru) 2009-08-10
EP1898888A2 (en) 2008-03-19
CN101252921A (zh) 2008-08-27
CA2613102A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
CR9597A (es) Formulaciones de estrogenos conjugados y bazedoxifeno
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
DE50104135D1 (de) Wässrige zusammensetzungen
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DE60142810D1 (de) Abführende Zusammensetzungen
MA30945B1 (fr) Anticorps anti-tat226 et immunoconjugués
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
ATE286109T1 (de) Benzinzusammensetzung
CR9746A (es) Bazedoxifene acetate formulations
HN2002000150A (es) Agentes antibacteriano
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
DE60129982D1 (de) Schweisshemmende zusammensetzungen
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
TW200730190A (en) New combination to treat liver fibrosis
BRPI0614413A2 (pt) composto, e, composição farmacêutica
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
TWI349545B (en) Pharmaceutical composition
BRPI0614412A2 (pt) composto, e, composição farmacêutica
GT200200094A (es) Microcapsulas para la proteccion frente al mal aliento
BR0113783B1 (pt) Composição aquosa
CL2004001921A1 (es) Compuestos derivados de pirimidina; composicion que los cintoene utiles como insecticidas y antihelminticos.
ATE415156T1 (de) 4-hydroxytamoxifengel-formulierungen
IT1318654B1 (it) Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)